6.0446
Apollomics Inc stock is traded at $6.0446, with a volume of 13,043.
It is down -0.09% in the last 24 hours and down -7.01% over the past month.
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
See More
Previous Close:
$6.05
Open:
$6.12
24h Volume:
13,043
Relative Volume:
0.49
Market Cap:
$6.67M
Revenue:
-
Net Income/Loss:
$-57.11M
P/E Ratio:
-0.403
EPS:
-15
Net Cash Flow:
$-34.82M
1W Performance:
+6.61%
1M Performance:
-7.01%
6M Performance:
-13.89%
1Y Performance:
-52.10%
Apollomics Inc Stock (APLM) Company Profile
Compare APLM with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
APLM
Apollomics Inc
|
6.0446 | 6.29M | 0 | -57.11M | -34.82M | -15.00 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Apollomics Inc Stock (APLM) Latest News
How to manage a losing position in Apollomics Inc.Weekly Investment Recap & Capital Efficient Trading Techniques - Newser
Reversal Confirmed Apollomics Inc. Equity Warrant Stock Rallies Above MAWall Street Watch & Verified Momentum Stock Ideas - Newser
Is Apollomics Inc. showing signs of accumulationJuly 2025 Big Picture & High Return Stock Watch Alerts - Newser
Ranking Apollomics Inc. among high performing stocks via tools2025 Major Catalysts & Daily Stock Trend Reports - Newser
What MACD signals say about Apollomics Inc. Equity WarrantJuly 2025 Closing Moves & Technical Pattern Based Buy Signals - Newser
How to escape a deep drawdown in Apollomics Inc. Equity Warrant2025 Fundamental Recap & Community Driven Trade Alerts - Newser
Using data filters to optimize entry into Apollomics Inc.2025 Institutional Moves & Fast Exit and Entry Strategy Plans - Newser
Should you wait for a breakout in Apollomics Inc.July 2025 Gainers & Weekly High Conviction Trade Ideas - Newser
Is Apollomics Inc. Equity Warrant stock bottoming outQuarterly Profit Review & Step-by-Step Swing Trade Plans - Newser
News impact scoring models applied to Apollomics Inc. Equity WarrantQuarterly Portfolio Report & Expert Curated Trade Setups - Newser
Apollomics Inc. Equity Warrant stock trend outlook and recovery path2025 Fundamental Recap & Daily Volume Surge Trade Alerts - Newser
Best data tools to analyze Apollomics Inc. Equity Warrant stock2025 Risk Factors & Weekly Watchlist for Consistent Profits - Newser
Can Apollomics Inc. Equity Warrant rally from current levelsJuly 2025 Levels & Low Drawdown Momentum Ideas - Newser
Automated trading signals detected on Apollomics Inc.GDP Growth & Weekly High Conviction Trade Ideas - Newser
Real time pattern detection on Apollomics Inc. Equity Warrant stockGap Up & Safe Swing Trade Setups - Newser
How to monitor Apollomics Inc. Equity Warrant with trend dashboardsProfit Target & Weekly Market Pulse Alerts - Newser
What high frequency data says about Apollomics Inc.July 2025 Macro Moves & Long-Term Growth Portfolio Plans - Newser
How to track smart money flows in Apollomics Inc.Portfolio Performance Summary & Low Risk Entry Point Guides - Newser
Visual analytics tools that track Apollomics Inc. Equity Warrant performance2025 Trading Recap & Fast Gaining Stock Strategy Reports - Newser
How sentiment analysis helps forecast Apollomics Inc. Equity Warrant - Newser
What recovery options are there for Apollomics Inc. Equity Warrant2025 Trading Recap & Risk Controlled Stock Alerts - Newser
Is Apollomics Inc. still worth holding after the dipWeekly Risk Report & AI Powered Market Entry Strategies - Newser
News impact scoring models applied to Apollomics Inc.Quarterly Growth Report & Stock Timing and Entry Methods - Newser
What’s the recovery path for long term holders of Apollomics Inc.Weekly Trend Report & AI Driven Stock Price Forecasts - Newser
Top chart patterns to watch in Apollomics Inc. Equity WarrantMarket Volume Report & Accurate Intraday Trade Tips - Newser
Earnings visualization tools for Apollomics Inc.2025 Market Overview & Community Consensus Picks - Newser
Published on: 2025-08-19 15:39:55 - Newser
Combining price and volume data for Apollomics Inc. Equity WarrantJobs Report & Free Community Consensus Stock Picks - Newser
Chart based analysis of Apollomics Inc. Equity Warrant trendsJuly 2025 Chart Watch & Risk Adjusted Buy and Sell Alerts - Newser
Is Apollomics Inc. Equity Warrant forming a reversal patternJuly 2025 Trade Ideas & Real-Time Volume Trigger Notifications - Newser
Will Apollomics Inc. continue its uptrendPrice Action & High Accuracy Trade Alerts - Newser
Advanced analytics toolkit walkthrough for Apollomics Inc.July 2025 Volume & Risk Managed Investment Signals - Newser
Apollomics, Inc. (NASDAQ:APLMW) Short Interest Update - Defense World
Momentum Screeners Rank Apollomics Inc. Equity Warrant in Top 5 TodayWeekly Profit Recap & AI Powered Market Entry Ideas - beatles.ru
Can trapped investors hope for a rebound in Apollomics Inc. Equity WarrantPortfolio Performance Summary & Fast Entry High Yield Tips - Newser
Short interest data insights for Apollomics Inc. Equity WarrantJuly 2025 PreEarnings & Weekly High Momentum Picks - Newser
What indicators show strength in IRONTrade Exit Summary & High Accuracy Trade Alerts - Newser
Will a bounce in Apollomics Inc. offer an exitJuly 2025 Intraday Action & AI Forecasted Entry and Exit Points - Newser
Exit strategy if you’re trapped in The Eastern CompanyAnalyst Downgrade & Accurate Buy Signal Alerts - Newser
Apollomics Inc Stock (APLM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):